WO2001022982A3 - Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract - Google Patents

Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract Download PDF

Info

Publication number
WO2001022982A3
WO2001022982A3 PCT/US2000/026752 US0026752W WO0122982A3 WO 2001022982 A3 WO2001022982 A3 WO 2001022982A3 US 0026752 W US0026752 W US 0026752W WO 0122982 A3 WO0122982 A3 WO 0122982A3
Authority
WO
WIPO (PCT)
Prior art keywords
sympathomimetic
side effects
serenoa repens
compositions
reducing
Prior art date
Application number
PCT/US2000/026752
Other languages
French (fr)
Other versions
WO2001022982A2 (en
Inventor
Anthony L Almada
Original Assignee
Imaginutrition Inc
Anthony L Almada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imaginutrition Inc, Anthony L Almada filed Critical Imaginutrition Inc
Priority to CA002384731A priority Critical patent/CA2384731A1/en
Priority to EP00965515A priority patent/EP1216050A2/en
Priority to AU76218/00A priority patent/AU7621800A/en
Publication of WO2001022982A2 publication Critical patent/WO2001022982A2/en
Priority to US10/044,645 priority patent/US6759063B2/en
Publication of WO2001022982A3 publication Critical patent/WO2001022982A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided are compositions including Serenoa repens and extracts thereof, in combination with a sympathomimetic agent, which may be used to control a variety of physical conditions, including obesity, appetite suppression, decongestion, asthma and energy stimulation.Serenoa repens, or extracts thereof, when added to dosage forms of pharmacologic agents with sympathomimetic activity, or when administered in combination with sympathomimetic agents, decreases side effects. Thus, debilitating side effects associated with use of pharmacologic agents that stimulate adrenergic receptors and display sympathomimetic effects can be reduced.
PCT/US2000/026752 1999-09-27 2000-09-27 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract WO2001022982A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002384731A CA2384731A1 (en) 1999-09-27 2000-09-27 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract
EP00965515A EP1216050A2 (en) 1999-09-27 2000-09-27 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract
AU76218/00A AU7621800A (en) 1999-09-27 2000-09-27 Methods and compositions for reducing sympathomimetic-induced side effects
US10/044,645 US6759063B2 (en) 1999-09-27 2002-01-10 Methods and compositions for reducing sympathomimetic-induced side effects

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15626299P 1999-09-27 1999-09-27
US60/156,262 1999-09-27

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US67210900A Continuation-In-Part 1999-09-27 2000-09-27
US10/044,645 Continuation-In-Part US6759063B2 (en) 1999-09-27 2002-01-10 Methods and compositions for reducing sympathomimetic-induced side effects

Publications (2)

Publication Number Publication Date
WO2001022982A2 WO2001022982A2 (en) 2001-04-05
WO2001022982A3 true WO2001022982A3 (en) 2002-03-14

Family

ID=22558809

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/026752 WO2001022982A2 (en) 1999-09-27 2000-09-27 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract

Country Status (5)

Country Link
EP (1) EP1216050A2 (en)
CN (1) CN1376069A (en)
AU (1) AU7621800A (en)
CA (1) CA2384731A1 (en)
WO (1) WO2001022982A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106520A (en) * 2015-10-06 2015-12-02 常州亚当生物技术有限公司 Healthcare product

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GUTIERREZ, M. ET AL: "Mechanisms involved in the spasmolytic effect of extracts from Sabal serrulata fruit on smooth muscle", GEN. PHARMACOL. (1996), 27(1), 171-6, 1996, XP000997265 *

Also Published As

Publication number Publication date
CN1376069A (en) 2002-10-23
AU7621800A (en) 2001-04-30
WO2001022982A2 (en) 2001-04-05
EP1216050A2 (en) 2002-06-26
CA2384731A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
ZA95743B (en) Therapeutic agents
WO2008094548A3 (en) Local delivery of therapeutic agent to heart valves
WO2004058717A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
WO2002036732A3 (en) Active variants of fgf with improved specificity
WO2003037246A3 (en) Compositions and methods for prostate and kidney health and disorders, an herbal preparation
WO2006068777A3 (en) Use of natural plant extracts in cosmetics compositions
EP1539205A4 (en) Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof
HK1074577A1 (en) The use of thymosin ß4 (Tß4), analogues, isoforms and other derivatives in the manufacture of a medicament for treating disorders of eye and the surrounding tissue
BG104397A (en) Extended release formulation
UA87513C2 (en) Pharmaceutical composition comprising drospirenone and ethynylestradiol
IL155097A0 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
RS51434B (en) Multi-phase contraceptive preparation based on a natural estrogen
WO2002056745A3 (en) Method of treating parkinson's disease
WO2001022982A3 (en) Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract
WO1998005354A3 (en) Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors
WO2002012245A3 (en) Azabicyclic derivatives and their therapeutic use
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
MD1140B1 (en) Remedy possessing a regenerative and cytoprotective activity
EP1161254A4 (en) Treatment of autoimmune diseases with american ginseng extract
NO20072687L (en) Pharmaceutical contraceptive preparation
WO2002045704A3 (en) Prevention and treatment of tachyphylactic response
DE60137528D1 (en) Humane adenylatcyclase
YAMAGUCHI Pelvic Floor Exercise in Treatment of Stress Urinary Incontinence
Voloshina et al. Group work as a form of psychological assistance for unemployed
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2384731

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 008134367

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2000965515

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000965515

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000965515

Country of ref document: EP